Report cover image

Age-Related Macular Degeneration: 68-Market Analysis and Sales Forecast

Publisher GlobalData
Published Dec 22, 2025
Length 20 Pages
SKU # GBDT20698351

Description

Age-Related Macular Degeneration: 68-Market Analysis and Sales Forecast

Summary

This report covers the 68 geographical markets and provides an Excel-based forecast model for the Age-Related Macular Degeneration (AMD) market.

Across the 68 markets, sales in the AMD market were $8.9 billion in 2024, growing to $24.1 billion in 2034.

The seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) represent approximately 87.0% and 85.2% in 68-market sales in 2024 and 2034, respectively.

Scope
  • This publication is an expanded version of the Excel model containing the patient-based forecast sales for AMD, covered in GlobalData’s report “Age-Related Macular Degeneration: Seven-Market Analysis and Sales Forecast”, published in December 2025. In addition to patient based forecast sales data for the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan), this report contains sales forecast extrapolations for an additional 60 geographical markets (60M), totaling 68 markets (68M).
Reasons to Buy
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the 68M AMD therapeutics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 68M AMD therapeutics market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Please note:this is deliverd as a zip file.

Table of Contents

20 Pages
1 Executive Summary
1.1 Overview
1.2 68M summary statistics
1.3 Key 7MM events driving the 68M forecast extrapolation
2 Appendix
2.1 Abbreviations
2.2 Methodology
2.2.1 Patient-based forecast methodology
2.2.2 68M forecast extrapolation methodology
2.3 Primary research - key opinion leaders interviewed for this report
2.3.1 Key opinion leaders
2.4 Primary research - prescriber survey
2.5 About the authors
2.5.1 Managing Analyst
2.5.2 Therapy area directors
2.5.3 Epidemiologist
2.5.4 Epidemiology reviewers
2.5.5 Vice President of Disease Intelligence and Epidemiology
2.5.6 Global Head and EVP of Healthcare Operations and Strategy
About GlobalData
Contact Us
List of Tables
Table 1: AMD market size across the 68M - 7MM versus 61M
Table 2: AMD market size across the 68M - by geographical region
Table 3: AMD key events occurring in the 7MM driving forecast trajectory in the 68M
Table 4: High-prescribing physicians (non-KOLs) surveyed, by country
List of Figures
Figure 1: AMD market size across the 68M - 7MM versus 61M
Figure 2: AMD market size across the 68M - by geographical region

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.